3Drobyski WR, MorseⅢ HC, Burns WH, et al.Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene[J]. Blood,2001,97:2506.
4Cohen JL,Boyer O,Klatzmann D.Suicide gene therapy of graft-versus-host disease:immune reconstitution with transplanted mature T cells[J]. Blood, 2001,98:2071.
5Speiser DE, Bachmann MF, Shahinian A, et al. Acute graft versus host disease without costimulation via CD28. Transplantation,1997, 63: 1042-1051.
6Kornblau SM, Stiouf I, Snell V, et al. Preemptive control of graft versus host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes. Cancer Res,2001,61: 3355-3360.
7Drobyski WR, Morse Ⅲ HC, Bums WH, et al. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood, 2001,97: 2506-2513.
8Contassot E, Ferrand C,Angonin R,et al. Ganciclovir-sensitive acute graft versus hostdisease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cellsin a bone marrow transplantation setting[J].Transplantation,2000,69:503.
9Drobyski WR,Gendelman M,Vodanovic-Jankovic S,et al.Elimination of leukemia in theabsence of lethal graft versus host disease after allogenic bone marrowtransplantation[J]. J Immunol,2003,170:3046.
10Litvinova E,Maury S,Boyer O,et al.Graft versus leukemia effect after suicide genemediated control of graft-versus-host disease[J]. Blood,2002,100:2020.
